Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Industrials · ·
$79.20
▼ $1.56 (-1.9%)
Market data updated: 09/16 06:35 AM
Fundamentals updated: 09/16/2026
News analyzed: 09/16/2026
Market Cap
$4.09B
Day Range
$78.37 - $80.51
52-Week Range
$58.33 - $94.53
Beta
—
Next Earnings
02.11.2026
CBT is a stock from the Industrials sector — Manufacturing, aerospace, defense, and infrastructure — closely tied to capital-investment cycles and economic growth.
+0.3% (1Y)
Strengths: 7/32 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🔴 Bearish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Operating margin stability
Operating margin is stable or improving over time
Quality
Biggest negative driver
Calmar Ratio (return vs. drawdown)
Calmar: 0.09 (3y annualized return 4.2% / max drawdown 49.8%)
Risk
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
48
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
26
Quality
58
Value
55
Momentum
19
Risk
48
Sentiment
86
Fundamental
71
Institutional
0
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of Cabot Corporation (CBT) has centered on its financial performance and strategic initiatives. The company reported a 4% sequential increase in adjusted earnings per share (EPS) in Q3 2026, driven by strength in its Performance Chemicals segment, though Reinforcement Materials faced margin pressure. Cabot also raised $350 million through a bond offering in August 2026 and announced a partnership with Ridgeline for wealth management solutions. Analysts debated stock recommendations, with JP Morgan maintaining an underweight rating while others suggested retaining shares amid shifting battery materials investments.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Cabot Corporation. News trend score: 86. Reason: 8 of the last 20 articles are positive, versus 2 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
18
🎯 Conviction (vs. Emotion)
40
Psychology
62
Fundamentals
71
Technical
19
Valuation
55
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
A significant decline over time, but on unusually low trading volume — holders unwilling to accept the loss.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
Price (3M)
-10%
Market Narrative
47
Fundamental Reality
40
Narrative Gap
+7
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market’s dominant herding behavior reflects CBT’s passive alignment with peers, as its +0.4% gain mirrors the sector’s +0.6% move. Anchoring (3.6% above support) and confirmation bias (narrative gap +10) imply traders may cling to narratives despite weak fundamentals. The absence of panic or euphoria suggests a cautious, consensus-driven environment. The key question: will traders break from herding if CBT’s momentum diverges further from peers? Low FOMO and overconfidence scores also indicate limited speculative enthusiasm, leaving room for external catalysts to shift behavior.
Updated: 09/08/2026, 01:12 PM
What could change this?
👥 What the crowd believes
"Cabot Corporation priced a public offering of $350 million of 4.950% senior unsecured notes due 2029"
"Cabot's Q3 fiscal 2026 earnings beat estimates as Performance Chemicals gains offset Reinforcement Materials margin pressure"
"JP Morgan analyst raises Cabot price target to $78 from $70"
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Samuel Armstrong Nelson — 94/100
🔴 Weakest match
Philip Fisher — 25/100
🗣️ Why do they disagree?
The scores for CBT span a wide spectrum—from Nelson’s strong 94 indicating a favorable cycle position to Fisher’s 25 suggesting a lack of the quality‑growth signature he required—highlighting how each methodology emphasizes different factors. Based on the documented principles of cycle‑focused investors like Nelson and Marks‑cycle, the model estimates a relatively neutral to favorable stance, whereas crowd‑sentiment analysts such as Mackay see no obvious mania, resulting in mid‑range scores. Value‑oriented frameworks (Graham, Graham‑Enterprising, Loeb) and growth‑oriented criteria (Lynch, Fisher, Livermore) assign lower marks, reflecting concerns about price valuation, profitability, or trend alignment. Consequently, the model estimates that the stock appears more attractive to cycle‑timers while being less compelling to strict value or growth investors.
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 94
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 77
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 59
Mixed — a good business, but expectations may already be high
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 59
No clear edge either way
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 57
Reasonable but not a clear long-term holding
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 56
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 52
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟡 49
Adequate but not exceptional liquidity
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 47
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 47
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 45
Mixed — doesn't clearly pass Graham's tests
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟡 40
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 33
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 27
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 27
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 25
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Based on the last 277 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (1 bullish · 10 bearish · 0 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear downtrend with no defined trading range in the period examined.
High confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
25.3%
Operating Margin
16.7%
Net Margin
8.9%
EBITDA Margin
20.9%
ROE
21.4%
ROA
8.7%
ROIC
—
EPS
$6.07
Cash
$258.00M
Total Debt
$1.12B
Current Ratio
1.61
Debt/Equity
0.72
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 28.8.2026 | $0.473 |
| 29.5.2026 | $0.473 |
| 28.5.2026 | $0.473 |
| 27.2.2026 | $0.450 |
| 26.2.2026 | $0.450 |
| 28.11.2025 | $0.450 |
| 27.11.2025 | $0.450 |
| 29.8.2025 | $0.450 |
| 28.8.2025 | $0.450 |
| 30.5.2025 | $0.450 |
| 29.5.2025 | $0.450 |
| 28.2.2025 | $0.430 |
How is Fair Value calculated? →
Current Price
$79.20
Estimated Fair Value (DCF)
$79.90
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
+0.9%
🟢 Appears cheap relative to estimated value
Year 1 Growth Rate
-4.8%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | -4.8% | $372.16M | $341.43M |
| 2 | -3.0% | $361.03M | $303.87M |
| 3 | -1.2% | $356.84M | $275.55M |
| 4 | 0.7% | $359.23M | $254.49M |
| 5 | 2.5% | $368.21M | $239.31M |
Base FCF (last actual year)
$391.00M
Terminal Value
$5.81B
Present Value of Terminal Value
$3.77B
Enterprise Value
$5.19B
Net Debt
$858.00M
Equity Value
$4.33B
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$28.60
Tangible Book Value per Share (Tangible NAV)
$25.11
Sentiment based on basic keywords (not AI) — 8 positive, 10 neutral, 2 negative out of the last 20 articles.
Yahoo · 15.9.2026
Benzinga · 15.9.2026
Yahoo · 9.9.2026
Yahoo · 2.9.2026
Zacks · 2.9.2026
Yahoo · 2.9.2026
Zacks · 2.9.2026
GlobeNewswire · 1.9.2026
GlobeNewswire · 12.8.2026
Yahoo · 12.8.2026
Motley Fool · 11.8.2026
Yahoo · 11.8.2026
Zacks · 10.8.2026
Yahoo · 10.8.2026
Benzinga · 7.8.2026
Benzinga · 5.8.2026
MT Newswires · 5.8.2026
SeekingAlpha · 5.8.2026
MarketBeat · 4.8.2026
GuruFocus.com · 4.8.2026
Cabot Corporation (CBT) currently has a StockIQ AI score of 48/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
CBT currently scores 48/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, CBT's estimated fair value is $79.90, which is 0.9% above the current price of $79.20. This is one valuation model among several signals in the fair-value category, not a price target.
CBT's technical score is 19/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Operating margin is stable or improving over time; Return on equity (ROE): 21.4% — strong; Current ratio: 1.61.
Based on the real signals StockIQ computed: Calmar: 0.09 (3y annualized return 4.2% / max drawdown 49.8%); Revenue growth (last year): -7.0%; Earnings per share (EPS) growth: -10.4%.
Yes — CBT has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 6 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Keohane Sean D | Open Market Sale | 28.8.2026 | 404,134 | -134,895 | $85.00 |
| Keohane Sean D | Exercise of Derivative Securities | 28.8.2026 | 539,029 | +134,895 | $50.00 |
| Keohane Sean D | Exercise of Derivative Securities | 28.8.2026 | 0 | -134,895 | — |
| Keohane Sean D | Exercise of Derivative Securities | 28.8.2026 | 134,895 | +134,895 | $50.00 |
| Keohane Sean D | Open Market Sale | 28.8.2026 | 134,895 | -134,895 | $85.00 |
| Keohane Sean D | Exercise of Derivative Securities | 28.8.2026 | 134,895 | -134,895 | — |
| Keohane Sean D | Exercise of Derivative Securities | 24.8.2026 | 291,652 | +2,779 | $50.00 |
| Keohane Sean D | Exercise of Derivative Securities | 24.8.2026 | 134,895 | +2,779 | — |
| Keohane Sean D | Open Market Sale | 24.8.2026 | 288,873 | -2,779 | $85.50 |
| Keohane Sean D | Open Market Sale | 24.8.2026 | 2,779 | -2,779 | $85.50 |
| Keohane Sean D | Exercise of Derivative Securities | 24.8.2026 | 2,779 | +2,779 | — |
| Keohane Sean D | Exercise of Derivative Securities | 24.8.2026 | 2,779 | +2,779 | $50.00 |
| Keohane Sean D | Exercise of Derivative Securities | 7.8.2026 | 0 | +91,923 | — |
| Keohane Sean D | Exercise of Derivative Securities | 7.8.2026 | 496,057 | +91,923 | $62.24 |
| Keohane Sean D | Open Market Sale | 7.8.2026 | 404,134 | -91,923 | $86.41 |
| Keohane Sean D | Exercise of Derivative Securities | 7.8.2026 | 91,923 | +91,923 | — |
| Keohane Sean D | Open Market Sale | 7.8.2026 | 91,923 | -91,923 | $86.41 |
| Keohane Sean D | Exercise of Derivative Securities | 7.8.2026 | 91,923 | +91,923 | $62.24 |
| Nathoo Raffiq | Grant/Award from Employer | 30.6.2026 | 261.506 | +261.506 | $90.82 |
| Keohane Sean D | Grant/Award from Employer | 30.6.2026 | 83.682 | +83.682 | $90.82 |
| Keohane Sean D | Grant/Award from Employer | 30.6.2026 | 47,831 | +84 | $90.82 |
| Nathoo Raffiq | Grant/Award from Employer | 30.6.2026 | 1,878 | +262 | $90.82 |
| Masterson William F III | Grant/Award from Employer | 12.6.2026 | 2.824 | +2.824 | $87.65 |
| McLaughlin Erica | Grant/Award from Employer | 12.6.2026 | 55.232 | +55.232 | $87.65 |
| Keohane Sean D | Grant/Award from Employer | 12.6.2026 | 256.014 | +256.014 | $87.65 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
4,558,932 shares short as of 2026-08-31 · vs. 3,759,946 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
74.5% of trading volume this week was short selling, vs. 75.1% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology